Science Explorer Interactive view Map
Company · Tel Aviv · Israel

Novartis (Israel)

Research works
4
▼ 90% vs 2013–17
Citations
37
9.2 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Novartis (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Novartis (Israel) publish most on?

By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Kruppel-like factors research and Myeloproliferative Neoplasms: Diagnosis and Treatment.

  1. 1 Hemoglobinopathies and Related Disorders Genetics 0 works
  2. 2 Kruppel-like factors research Molecular Biology 0 works
  3. 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.7%not open50.3%

World: 28% of research is openly available.

with international co-authors21.4%domestic only78.6%

World: 19% is written across borders.

How has Novartis (Israel)'s research output changed?

Output in 2018–2022 was 90% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tel Aviv

All research institutions in Tel Aviv

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.